by administrator | Nov 7, 2017 | Appili Therapeutics, News
See original post here For Immediate Release November 7, 2017 – HALIFAX, Nova Scotia –– Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today it has been awarded a $1.2 million USD grant by the Department of...
by administrator | Nov 2, 2017 | Appili Therapeutics, News
For Immediate Release HALIFAX, Nova Scotia – October 30, 2017 – Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today that both the US Food and Drug Administration (FDA) and Health Canada have cleared its IND...
by administrator | Oct 23, 2017 | Appili Therapeutics, News
For Immediate Release October 23, 2017 – HALIFAX, Nova Scotia –– Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today it raised $3,062,000 in a private placement financing, bringing the total equity raised...
by administrator | Jul 26, 2016 | Appili Therapeutics, News
entrevestor.com, written by Peter Moreira Kevin Sullivan had the pride of a guy showing off his new Cadillac. But it wasn’t a car he was displaying, it was the new laboratory that his company had recently moved into. The company is Halifax-based drug discovery outfit...
by administrator | Apr 12, 2016 | Appili Therapeutics, News
See original post here HALIFAX, Nova Scotia – April 12, 2016 – Appili Therapeutics Inc., an anti-infective pharmaceutical development company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ATI-1501, a...
